$67.93
-0.77 (-1.13%)
Medivation, Inc. (NASDAQ:MDVN)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.